---
layout: post
title: "Modernizing the Food and Drug Administration's Premarket Notification Program; Draft Guidances for Industry and Food and Drug Administration Staff; Availability"
date: 2026-02-05 18:56:44 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-19283
original_published: 2023-09-07 00:00:00 +0000
significance: 8.00
---

# Modernizing the Food and Drug Administration's Premarket Notification Program; Draft Guidances for Industry and Food and Drug Administration Staff; Availability

**Published:** February 05, 2026 18:56 UTC
**Source:** Federal Register
**Original Published:** September 07, 2023 00:00 UTC
**Document Number:** 2023-19283

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of three draft guidances entitled "Evidentiary Expectations for 510(k) Implant Devices," "Recommendations for the Use of Clinical Data in Premarket Notification [510(k)] Submissions," and "Best Practices for Selecting a Predicate Device to Support a Premarket Notification [510(k)] Submission." FDA is issuing these guidances to improve the predictability, consistency, and transparency of the 510(k) premarket review process. The draft guidances are not final nor are they for implementation at this time.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/09/07/2023-19283/modernizing-the-food-and-drug-administrations-premarket-notification-program-draft-guidances-for)
- API: https://www.federalregister.gov/api/v1/documents/2023-19283

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
